Pinned Tweet
An excellent publication by Dr. Patrick O'Byrne - outlining the high sensitivity and specificity of our Multiplo® TP/nTP rapid test. A unique tool to rapid diagnose infectious syphilis and a one-stop solution to improve medical stewardship.
link.springer.com/article/10…
When used alongside clinical assessment and established staging algorithms, dual TP/nTP point-of-care testing can improve both timely treatment and antibiotic stewardship.”
link.springer.com/article/10…
Syphilis is on the rise globally, easy-to-use and high quality POC tests are a key to fight this concerning situation. MedMira's Multiplo TP/nTP is an affordable and highly efficient solution.
health.gov.au/news/syphilis-…
Now available on NIH's Medical Library of Medicine_
pubmed.ncbi.nlm.nih.gov/4136…
With MedMira's patented RVF Technology - the possibilities are endless.
Available world-wide for RUO use:
MedMira's unique and patented technology gives you the flexibility to built your rapid test as you desire. For Point-of-Care use or Research...MedMira offers a myriad of possibilities with it's unique Miriad product line.
Helping People Know...
Nothing is quicker to get you the answer you need: MedMira's RVF Technology gives you answer(s) NOW.
No matter the sample.
At MedMira we are dedicated to innovate and change the norm. Bringing the fastest rapid tests to the world was our first step.
The next evolution in motion:
MiROQ taking Rapid Testing to a Quantitative level!
Helping People Know...
MedMira retweeted
#ICYMI: Health Canada has approved @MedMira Reveal® TP — the fastest standalone syphilis test in Canada. A vital tool for frontline healthcare workers, especially as syphilis rates surge across the Prairies. finance.yahoo.com/news/healt…










